FDA loosens the belt on Lap-Band surgery
After rejecting the approval of three new weight-loss drugs in the past few months, the FDA on Wednesday implemented a change which represents a minor advance in the fight against the obesity epidemic: lowering the requirements for patients who wish to use Allergan’s Lap-Band stomach-restricting device. Now, people with a body mass index (BMI) of 30 and an associated obesity-related health condition, such as hypertension or diabetes, are eligible for the procedure.
